Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SERUM FATTY ACIDS IN MULTIPLE SCLEROSIS.

Literature DB >> 14213469

SERUM FATTY ACIDS IN MULTIPLE SCLEROSIS.

Abstract

Entities: Chemical Disease

Keywords: ADOLESCENCE; BLOOD LIPIDS; CHROMATOGRAPHY; CLINICAL RESEARCH; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; GERIATRICS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES

Mesh：

Substances：

Year: 1964 PMID： 14213469 PMCID： PMC495769 DOI： 10.1136/jnnp.27.5.408

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

× No keyword cloud information.

12 in total

1. LIPID STUDIES OF WHITE MATTER AND THALAMUS OF HUMAN BRAINS.

Authors: B GERSTL; M G TAVASTSTJERNA; R B HAYMAN; J K SMITH; L F ENG
Journal: J Neurochem Date: 1963-12 Impact factor: 5.372

2. The determination of total lipides in blood serum.

Authors: W M SPERRY; F C BRAND
Journal: J Biol Chem Date: 1955-03 Impact factor: 5.157

3. Fatty-acid composition of brain lecithins in multiple sclerosis.

Authors: R W BAKER; R H THOMPSON; K J ZILKHA
Journal: Lancet Date: 1963-01-05 Impact factor: 79.321

4. The fatty acids of the human cerebrospinal fluid: their relation to the serum fatty acids. A study using gas-liquid chromatography.

Authors: N TUNA; J LOGOTHETIS; R KAMMERECK
Journal: Neurology Date: 1963-04 Impact factor: 9.910

5. The fatty acid patterns of plasma lipids during alimentary lipemia.

Authors: V P DOLE; A T JAMES; J P WEBB; M A RIZACK; M F STURMAN
Journal: J Clin Invest Date: 1959-09 Impact factor: 14.808

6. Serum lipids in patients with multiple sclerosis.

Authors: B GERSTL; W E DAVIS; J K SMITH; P M RAMORINO; D L ORTH
Journal: Am J Clin Pathol Date: 1957-03 Impact factor: 2.493

7. The biosynthesis of the fatty acids of the plasma of man. I. The formation of certain chromatographically separated higher fatty acids of the major lipide complexes from acetate-1-C14.

Authors: S R LIPSKY; A HAAVIK; C L HOPPER; R W MCDIVITT
Journal: J Clin Invest Date: 1957-02 Impact factor: 14.808

8. Deficiency of essential fatty acids and atherosclerosis, etcetera.

Authors: H M SINCLAIR
Journal: Lancet Date: 1956-04-07 Impact factor: 79.321

9. A relation between non-esterified fatty acids in plasma and the metabolism of glucose.

Authors: V P DOLE
Journal: J Clin Invest Date: 1956-02 Impact factor: 14.808

10. Multiple sclerosis; a correlation of its incidence with dietary fat.

Authors: R L SWANK
Journal: Am J Med Sci Date: 1950-10 Impact factor: 2.378

22 in total

1. SERUM CHOLESTEROL LINOLEATE LEVELS IN MULTIPLE SCLEROSIS.

Authors: R W BAKER; H SANDERS; R H THOMPSON; K J ZILKHA
Journal: J Neurol Neurosurg Psychiatry Date: 1965-06 Impact factor: 10.154

2. Serial levels of plasma linoleic acid in tetanus.

Authors: N Callaghan; B Kearney; W C Love
Journal: Ir J Med Sci Date: 1976-12 Impact factor: 1.568

3. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.

Authors: J H Millar; K J Zilkha; M J Langman; H P Wright; A D Smith; J Belin; R H Thompson
Journal: Br Med J Date: 1973-03-31

4. Gas liquid chromatographic analysis of sphingosine bases in sphingolipids of human normal and multiple sclerosis cerebral white matter.

Authors: E A Moscatelli; E Isaacson
Journal: Lipids Date: 1969-11 Impact factor: 1.880

10. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors: M I Hunter; B C Nlemadim; D L Davidson
Journal: Neurochem Res Date: 1985-12 Impact factor: 3.996